VON RICKENBACH JOSEF H
SEC insider (Form 3/4/5 filer). CIK 0001007706. Director at Aileron Therapeutics, Inc. (ALRN). 6 reported Form 4/5 transactions since Sep 2024; latest on May 27, 2026. Located in AUSTIN, TX.
Companies VON RICKENBACH JOSEF H has filed insider reports for
- Aileron Therapeutics, Inc. (ALRN): Director
VON RICKENBACH JOSEF H
CIK: 0001007706
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Aileron Therapeutics, Inc.
Discretionary Trading P&L
Holdings
Transaction History (6 total)
- May 27, 2026RNTX
Rein Therapeutics, Inc.
PurchaseDirect4.5K shares at avg. $1.07$5K - May 26, 2026RNTX
Rein Therapeutics, Inc.
PurchaseDirect23.2K shares at avg. $1.06$24K - May 22, 2026RNTX
Rein Therapeutics, Inc.
PurchaseDirect16K shares at avg. $1.05$17K - May 21, 2026RNTX
Rein Therapeutics, Inc.
PurchaseDirect3.4K shares at avg. $1.04$4K - Jul 23, 2025RNTX
Rein Therapeutics, Inc.
AwardDirectStock Option (right to buy)
17.5K shares- - Dec 2, 2024ALRN
Aileron Therapeutics, Inc.
AwardDirectStock Option (right to buy)
35K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| May 27, 2026 |  RNTX Rein Therapeutics, Inc. | Purchase | 4,500 | $1.07 | $4,819 | Direct |
| May 26, 2026 | RNTX Rein Therapeutics, Inc. | Purchase | 23,190 | $1.06 | $24,470 | Direct |
| May 22, 2026 | RNTX Rein Therapeutics, Inc. | Purchase | 15,950 | $1.05 | $16,708 | Direct |
| May 21, 2026 | RNTX Rein Therapeutics, Inc. | Purchase | 3,420 | $1.04 | $3,564 | Direct |
| Jul 23, 2025 | RNTX Rein Therapeutics, Inc. | Award Stock Option (right to buy) | 17,500 | - | - | Direct |
| Dec 2, 2024 | ALRN Aileron Therapeutics, Inc. | Award Stock Option (right to buy) | 35,000 | - | - | Direct |
1-6 of 6 transactions